We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$2.09B
Cap. Flow
-$1.4B
Cap. Flow %
-8.24%
Top 10 Hldgs %
32.24%
Holding
303
New
25
Increased
89
Reduced
109
Closed
31

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$187M
2
APH icon
Amphenol
APH
+$160M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
FSLR icon
First Solar
FSLR
+$101M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$101M

Top Sells

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$783M
2
NVDA icon
NVIDIA
NVDA
+$273M
3
AMD icon
Advanced Micro Devices
AMD
+$178M
4
CRM icon
Salesforce
CRM
+$110M
5
CDNS icon
Cadence Design Systems
CDNS
+$96.6M

Sector Composition

Rank Sector Weight
1 Technology 45.69%
2 Healthcare 18.55%
3 Financials 15.91%
4 Communication Services 12.03%
5 Consumer Discretionary 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
76
AbbVie
ABBV
$454B
$55.2M 0.33%
321,792
-2,384
-0.7% -$395K
NU icon
77
Nu Holdings
NU
$69.6B
$53.5M 0.32%
4,148,172
+2,723,994
+191% +$31.7M
MA icon
78
Mastercard
MA
$503B
$53M 0.31%
120,122
+3,324
+3% +$1.51M
HCA icon
79
HCA Healthcare
HCA
$92.4B
$53M 0.31%
164,934
-47,186
-22% -$15.3M
BIIB icon
80
Biogen
BIIB
$32.1B
$52.2M 0.31%
225,000
-75,000
-25% -$16.3M
HGTY icon
81
Hagerty
HGTY
$1.51B
$52M 0.31%
5,000,000
– –
SUPN icon
82
Supernus Pharmaceuticals
SUPN
$2.41B
$51.9M 0.31%
1,940,510
– –
BRK.B icon
83
Berkshire Hathaway Class B
BRK.B
$1.1T
$49.4M 0.29%
121,488
-489
-0.4% -$200K
GLOB icon
84
Globant
GLOB
$1.75B
$47.7M 0.28%
267,715
+92,839
+53% +$16.4M
BSX icon
85
Boston Scientific
BSX
$65.3B
$47M 0.28%
610,599
-38,404
-6% -$2.81M
JPM icon
86
JPMorgan Chase
JPM
$931B
$46.9M 0.28%
231,980
-18,256
-7% -$3.57M
RNAM
87
DELISTED
Avidity Biosciences
RNAM
$45.5M 0.27%
+1,114,101
New +$32M
AFL icon
88
Aflac
AFL
$58.7B
$43.3M 0.26%
485,000
– –
ITGR icon
89
Integer Holdings
ITGR
$4.28B
$42.1M 0.25%
363,969
+35,301
+11% +$4.12M
APLS
90
DELISTED
Apellis Pharmaceuticals
APLS
$41.4M 0.24%
1,079,440
+25,000
+2% +$1.13M
SE icon
91
Sea Limited
SE
$66.6B
$40.7M 0.24%
569,183
+143,074
+34% +$9.45M
TRUP icon
92
Trupanion
TRUP
$1.09B
$40.1M 0.24%
1,362,500
+112,500
+9% +$2.98M
KSPI icon
93
Kaspi.kz JSC
KSPI
$19.1B
$38.5M 0.23%
298,490
+97,901
+49% +$12M
ICLR icon
94
Icon
ICLR
$13B
$38.4M 0.23%
122,572
+25,482
+26% +$7.99M
SYK icon
95
Stryker
SYK
$108B
$38.4M 0.23%
112,801
+89,807
+391% +$30.4M
ICE icon
96
Intercontinental Exchange
ICE
$88.4B
$37.7M 0.22%
275,334
+16,172
+6% +$2.17M
SWTX
97
DELISTED
SpringWorks Therapeutics
SWTX
$37.7M 0.22%
1,000,000
+650,000
+186% +$27.4M
FDMT icon
98
4D Molecular Therapeutics
FDMT
$728M
$36.6M 0.22%
1,744,857
-53,635
-3% -$1.35M
LBPH
99
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$36.6M 0.22%
1,354,505
+49,074
+4% +$968K
RLI icon
100
RLI Corp
RLI
$5.63B
$36.6M 0.22%
520,000
– –
2 3
4
5 6

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Polar Capital Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, Polar Capital Holdings held 303 positions worth $17B, down 11% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Polar Capital Holdings withdrew a net $1.4B in Q2 2024, closing 31 positions and reducing 109 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in First Solar worth $105M.

  • Polar Capital Holdings's largest Q2 2024 buy was First Solar: 463,764 shares worth $105M.
  • Polar Capital Holdings added most to Broadcom in Q2 2024, an estimated $187M increase.
  • Polar Capital Holdings's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $273M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q2 2024, selling an estimated $783M.
  • Polar Capital Holdings's ten largest holdings make up 32% of its $17B portfolio in Q2 2024.
  • Polar Capital Holdings opened 25 new positions and closed 31 in Q2 2024.
  • Polar Capital Holdings's portfolio value fell 11% quarter-over-quarter to $17B.

Based on Polar Capital Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.